Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Clark William D Create: Alert

All | News | Filings
Date FiledTypeDescription
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 3,924 shares @ $1.25, valued at $4.9k
03/17/2022 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 150,000 shares @ $0
Sold 11,435 shares @ $1.1, valued at $12.6k
Granted 450,000 options to buy @ $1.11, valued at $499.5k
03/16/2022 5 Clark William D (President and CEO) has filed a Form 5 on GENOCEA BIOSCIENCES, INC.
12/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2020 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Bought 4,760 shares @ $2.06, valued at $9.8k
06/02/2020 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 27,344 shares @ $0
Granted 106,688 options to buy @ $2.72, valued at $290.2k
04/06/2020 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 50,783 shares @ $0
Granted 187,500 options to buy @ $1.66, valued at $311.3k
03/18/2019 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Exercised 15,000 options to buy @ $0.54, valued at $8.1k
02/11/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2018 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 468,000 options to buy @ $0.98, valued at $458.6k
06/07/2018 4 Clark William D (Director) has filed a Form 4 on Arsanis, Inc.
Txns: Granted 10,000 options to buy @ $16.99, valued at $169.9k
03/05/2018 4/A Clark William D (Director) has filed a Form 4 on Arsanis, Inc.
Txns: Granted 25,000 options to buy @ $10, valued at $250k
02/12/2018 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 396,000 options to buy @ $0.98, valued at $388.1k
01/19/2018 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Bought 25,000 shares @ $0.8, valued at $20k
12/01/2017 4 Clark William D (Director) has filed a Form 4 on Arsanis, Inc.
Txns: Granted 7,324 options to buy @ $10, valued at $73.2k
11/15/2017 3 Clark William D (Director) has filed a Form 3 on Arsanis, Inc.
03/01/2017 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
11/09/2016 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
02/04/2016 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 288,000 options to buy @ $3.09, valued at $889.9k
12/16/2015 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Bought 3,800 shares @ $6.45, valued at $24.5k
03/02/2015 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 138,000 options to buy @ $9.08, valued at $1.3M
12/15/2014 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Exercised 19,807 options to buy @ $2.86, valued at $56.6k
09/04/2014 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Exercised 20,000 options to buy @ $2.86, valued at $57.2k
02/11/2014 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Granted 81,670 options to buy @ $3.45, valued at $281.8k
02/23/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/19/2010 4 Clark William D (Sr. VP, Chief Business Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.
Txns: Exercised 25,000 restricted stock units @ $0
01/05/2010 4 Clark William D (Sr. VP, Chief Business Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.
Txns: Granted 30,000 restricted stock units @ $0
12/18/2009 4 Clark William D (Sr. VP, Chief Business Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.
Txns: Granted 70,000 options to buy @ $10.65, valued at $745.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy